Wednesday, February 10, 2010, 5:31am EST - Canadian Markets open in 3 hours and 59 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Sangamo Biosciences Inc. (SGMO)

On Feb 9: 4.85 USD   0.00 (0.00%)  
MORE ON SGMO
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Thu, Feb 4, 2010
New Star Analyst Rankings for Sangamo BioSciences, Inc.
StarMine (Thu, Feb 4)
Wed, Feb 3, 2010
Sangamo BioSciences, Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Wed, Feb 3)
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
EDGAR Online (Wed, Feb 3)
Sangamo BioSciences Reports Fourth Quarter and Full Year 2009 Financial Results
PRNewswire (Wed, Feb 3)
Q4 2009 Sangamo BioSciences Earnings Release - After Market Close
CCBN (Wed, Feb 3)
Mon, Feb 1, 2010
Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
PRNewswire (Mon, Feb 1)
Wed, Jan 27, 2010
Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
PRNewswire (Wed, Jan 27)
Tue, Jan 19, 2010
Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS
PRNewswire (Tue, Jan 19)
Mon, Jan 11, 2010
Stocks to Watch at Biotech’s Bellwether Conference
at Minyanville.com (Mon, Jan 11)
Sangamo plans another mid-stage neuropathy trial
at Reuters (Mon, Jan 11)
Sangamo BioSciences Advances ZFP Therapeutic(TM) Pipeline
PRNewswire (Mon, Jan 11)
Wed, Jan 6, 2010
Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
PRNewswire (Wed, Jan 6)
Thu, Dec 31, 2009
[video] Stock Picking By Management Teams
at CNBC (Thu, Dec 31)
Wed, Dec 9, 2009
Sangamo says early data from ALS study is positive
AP (Wed, Dec 9)
Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
PRNewswire (Wed, Dec 9)
Wed, Nov 18, 2009
Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
PRNewswire (Wed, Nov 18)
Fri, Nov 6, 2009
SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
Wed, Nov 4, 2009
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
EDGAR Online (Wed, Nov 4)
Fri, Oct 30, 2009
4-Star Stocks on the Upswing
at Motley Fool (Fri, Oct 30)
Tue, Oct 13, 2009
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi
EDGAR Online (Tue, Oct 13)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices